SAN LEANDRO, Calif.—Alpha Innotech Corp., a provider of bioan­alytical systems for drug discovery and life science research, recently announced a marketing agreement with CombiMatrix Molecular Diagnostics to mutually pro­mote and distribute an integrated analysis solution for comparative genomic hybridization (CGH).

 

The agreement is centered on the synergies between Alpha Innotech's AlphaScan laser scan­ner and CMDX's CGH arrays for neonatal screening and bio­marker discovery. As part of the deal, CombiMatrix Molecular Diagnostics will integrate Alpha Innotech's AlphaScan scanner into its CGH platform. Financial terms were not disclosed.

 

"We believe customers will appreciate a turnkey solution that combines DNA content, a reader, analysis software, and a validated laboratory protocol into a single integrated package," says Sia Ghazvini, VP of business devel­opment at Alpha Innotech. "We intend to continue partnering with leading application developers like CMDX to provide best-of-class, application-focused integrated solutions for their customers."